GlassScriptPhysician profile
Shannon Leonard
NPI 1871269316
$4,403.98
in general payments reported to CMS, 2019-2025
21 companies · $815 in 2025
The $815 reported for 2025 was more than what 88% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $124 · 2022: $263 · 2023: $1,893 · 2024: $1,310 · 2025: $815.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,589 · Travel and Lodging: $1,428.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,589.08 |
| Travel and Lodging | $1,427.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,177.33 | 2023-2025 | Air Optix, Dailies Aqua Comfort Plus, Dailies Total1 Multifocal |
| Sun Pharmaceutical Industries INC. | $461.31 | 2021-2025 | Cequa |
| Rxsight INC | $249.79 | 2024-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Light Adjustable Lens (Lal) |
| Astellas Pharma US INC | $184.09 | 2024-2025 | Izervay, Veozah |
| Apellis Pharmaceuticals, INC. | $139.94 | 2023 | Syfovre |
| Johnson & Johnson Vision Care, INC. | $139.01 | 2025 | Acuvue |
| Ani Pharmaceuticals, INC. | $128.24 | 2024-2025 | Purified Cortrophin Gel, Yutiq, Iluvien |
| Harrow Eye, LLC | $120.91 | 2024-2025 | Vevye |
| New World Medical,INC. | $120.48 | 2024 | Clearpath, Streamline, Ahmed Glaucoma Valve |
| Tarsus Pharmaceuticals, INC. | $118.83 | 2024-2025 | Xdemvy |
| Biotissue Holdings INC. | $106.74 | 2024 | |
| Allergan, INC. | $95.30 | 2022 | |
| Coopervision INC. | $77.55 | 2024-2025 | Myday Contact Lens |
| Genentech USA, INC. | $61.31 | 2024-2025 | Vabysmo |
| Bausch & Lomb Americas INC. | $60.77 | 2023-2025 | Miebo, Xipere, Infuse |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sandoz INC. | $33.29 | 2024 | Cimerli |
| Regeneron Healthcare Solutions, INC. | $31.58 | 2022-2023 | Eylea |
| Oyster Point Pharma, INC. | $30.93 | 2024 | Tyrvaya |
| Abbvie INC. | $29.06 | 2024-2025 | |
| Rayner Intraocular Lenses Limited | $25.28 | 2024 | Omidria |
| Novartis Pharmaceuticals Corporation | $12.24 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shannon Leonard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.